NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of MarineMax, Inc. (“MarineMax” or the “Company”) (NYSE: HZO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The legal-themed advertisement builds on a Superbowl 2024 campaign, and sees Heidi N Closet and Rife try to defend their clients from overpriced beauty products.

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dow Inc. (“Dow” or the “Company”) (NYSE: DOW). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Alico, Inc. (NASDAQ:ALCO ) Q3 2025 Earnings Call August 13, 2025 8:30 AM ET Company Participants Bradley Heine - Chief Financial Officer & Accounting Officer John E. Kiernan - President, CEO & Director Conference Call Participants Brandon B.

Toast's 78% surge in a year highlights strong growth and innovation, but lofty valuation and macro headwinds loom large.

BEN hits a 52-week high on strong AUM growth, acquisitions and solid capital returns but rising expenses pose risks ahead.

NBIS posts massive Q2 growth and ups ARR forecast, but faces stiff competition, high spending and scaling risks ahead.

Franco-Nevada Corporation posted record Q2 revenue and earnings, driven by historic gold prices, strong portfolio performance, and industry-leading margins. Valuation remains at a significant premium, reflecting market confidence but leaving limited short-term upside. Diversification across gold, PGM, and energy assets provides resilience against single-commodity volatility.

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

FSLR's risk-reward profile is a lot more compelling upon the clarity from One Big Beautiful Bill, with the 45x tax credits likely to sustain its rich profit margins. This is on top of the strategic monetization from the tax credit transfers, allowing the management to fund the ongoing capex expansions in the US. Combined with the discounted valuations, healthy balance sheet, & FQ2'25 new bookings, we can understand why the stock has recorded rich recoveries since the April 2025 bottom.

Novo Nordisk remains a buy despite share price weakness, as strong earnings and robust market share in diabetes and obesity care drive growth. The company's pipeline is rich, with late-stage R&D in obesity, cardiovascular, and rare diseases, including promising drugs like oral semaglutide and Mim8. Shareholder returns are supported by strong free cash flow, double-digit profit growth, and disciplined capital expenditures for future expansion.

Amazon has begun adding perishable groceries to its Same-Day Delivery service in the United States.

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Duolingo, Inc. (“Duolingo” or the “Company”) (NASDAQ: DUOL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

HAL's next-gen Summit Knowledge digital ecosystem boosts ESP performance with real-time insights, predictive tools and enhanced control.

NEXT secures $1.8B from TotalEnergies and GIP to advance the Train 4 expansion at its Rio Grande LNG facility in Texas.

PPL is investing heavily in transmission and distribution upgrades to improve service reliability.

Does NLY's high dividend yield, diversified mortgage portfolio and rising net interest income keep it attractive despite valuation concerns? Let us find out.

Regardless of this year's stock market volatility, the explosive demand for semiconductors and microchips that has grabbed news headlines and led the market higher over the past few years remains.

NEW YORK, NY / ACCESS Newswire / August 13, 2025 / The United Nations (UN) plastics treaty talks, described as the most important environmental negotiations since the Paris Agreement, are straining under the weight of competing agendas. Over 100 countries and a coalition of scientists, non-governmental organizations (NGOs), and policymakers want aggressive measures: production caps, chemical phase-outs, and bans on harmful single-use plastics.

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.